|
Market Closed -
OTC Markets
10:42:53 2026-07-15 EDT
|
5-day change | 1st Jan Change | ||
| 0.000001 USD | -.--% |
|
-.--% | - |
| Market Cap | 6.24M 4.49M 3.89M 3.67M 3.32M 429M 6.29M 43.77M 16.83M 218M 16.85M 16.48M 692M | P/E 2022 |
-2.09x | P/E 2023 | -0.45x |
|---|---|---|---|---|---|
| Enterprise Value | 64.5M 46.37M 40.19M 37.91M 34.37M 4.43B 64.99M 453M 174M 2.26B 174M 170M 7.16B | EV / Sales 2022 |
3.37x | EV / Sales 2023 | 1.35x |
| Free-Float |
52.66% | Yield 2022 * |
-
| Yield 2023 | - |
| Current year | 0 |  | 0 |
| 1 year | 0 | | 0 |
| 3 years | 0 | | 0.25 |
| 5 years | 0 | | 0.84 |
| 10 years | 0 | | 1.4 |
| Manager | Title | Age | Since |
|---|---|---|---|
Pascal Tougas
DFI | Director of Finance/CFO | - | 2023-11-19 |
Nelly Komari
CTO | Chief Tech/Sci/R&D Officer | - | 2021-05-31 |
Frédéric Dumais
IRC | Investor Relations Contact | - | 2019-05-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Steven Saviuk
CHM | Chairman | 67 | 2024-08-05 |
Richard MacKay
CHM | Chairman | 91 | 2018-07-24 |
Marc Léger
BRD | Director/Board Member | 67 | 2022-04-26 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 11/11/24 | Other | Investor Relations Manager | 0 | 0% | ||
| 11/11/24 | Other | Investor Relations Manager | 0 | 0% | ||
| 11/11/24 | Other | Investor Relations Manager | 0 | 0% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 98 | |
| +2.02% | -0.96% | +50.69% | +90.07% | 994B | |
| +0.28% | -3.24% | +49.57% | +62.40% | 640B | |
| +1.81% | +2.07% | +19.89% | +73.17% | 454B | |
| +5.00% | +1.23% | +36.64% | +40.84% | 337B | |
| +1.68% | -12.09% | +15.25% | +26.83% | 261B | |
| +3.81% | +1.23% | +3.05% | +14.86% | 246B | |
| +1.10% | -12.75% | +38.03% | +48.31% | 204B | |
| +1.43% | -6.19% | -19.49% | -58.38% | 190B | |
| +1.87% | -3.04% | +27.81% | +89.38% | 178B | |
| Average | +1.40% | -5.18% | +24.60% | +43.05% | 350.48B | |
| Weighted average by Cap. | +1.04% | -4.42% | +33.46% | +57.60% |
| 2022 | 2023 | |
|---|---|---|
| Net sales | 27.74M 19.95M 17.29M 16.31M 14.79M 1.91B 27.96M 195M 74.86M 971M 74.97M 73.31M 3.08B | 53.91M 38.76M 33.59M 31.69M 28.73M 3.7B 54.33M 378M 145M 1.89B 146M 142M 5.98B |
| Net income | -25.75M -18.51M -16.04M -15.13M -13.72M -1.77B -25.94M -181M -69.47M -901M -69.56M -68.03M -2.86B | -27.81M -19.99M -17.33M -16.34M -14.82M -1.91B -28.02M -195M -75.03M -973M -75.14M -73.48M -3.09B |
| Net Debt | 38.94M 28M 24.26M 22.89M 20.75M 2.68B 39.24M 273M 105M 1.36B 105M 103M 4.32B | 58.26M 41.89M 36.3M 34.24M 31.05M 4B 58.71M 409M 157M 2.04B 157M 154M 6.47B |
Employees
70
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- VPHIF Stock
Select your edition
All financial news and data tailored to specific country editions
